Shapiro Haber & Urmy LLP Announces It Has Filed a Securities Fraud Class Action Lawsuit Against InVivo Therapeutics Holdings Corp. (NVIV)

(Boston, MA) The Boston, MA law firm Shapiro Haber & Urmy LLP filed a class action suit on July 31, 2014 against InVivo Therapeutics Holdings Corp. (“InVivo”) and its former Chairman and CEO for violations of federal securities laws. The case has been filed in the United States District Court for the District of Massachusetts and is entitled Battle Construction Co., Inc.v. InVivo Therapeutics Holdings Corp., et al., C.A. No. 14-cv-13180.

The Complaint alleges that the Defendants made false and misleading statements about the FDA’s approval of a clinical trial and the time for completion of the trial and submission of data to the FDA. The Complaint alleges that these misstatements and omissions by Defendants misrepresented and/or omitted material facts to the investing public, in violation of Sections 10(b) and 20(a) of the Securities Exchange Act.

The class action is brought on behalf of all persons and entities who purchased common stock of InVivo from April 5, 2013 through August 26, 2013.

The factual and legal bases for the Plaintiff’s claims are set forth in greater detail in the Complaint, which is available here or can be obtained, without any obligation, from counsel for the Plaintiff, Shapiro Haber & Urmy LLP. If you would like more information about this case, please contact the firm at the telephone numbers below or by email.

Shapiro Haber & Urmy LLP
Thomas G. Shapiro
Boston, MA 02210
(800) 287-8119 or (617) 439-3939